Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.36B 1.17B 1.08B 1.01B 1.9B 129B 1.92B 12.71B 4.96B 62.88B 5.1B 4.99B 218B P/E Ratio 2026 *
26.9x
P/E Ratio 2027 * 14.6x
Enterprise Value 2.7B 2.32B 2.14B 2.01B 3.77B 255B 3.82B 25.23B 9.84B 125B 10.12B 9.9B 433B EV / Sales 2026 *
1.61x
EV / Sales 2027 * 1.46x
Free-Float
72.35%
Yield 2026 *
-
Yield 2027 * -
1 day+1.43%
1 week+4.55%
Current month+10.41%
1 month+25.60%
3 months+91.67%
6 months+31.48%
Current year+42.59%
1 week 16.75
Extreme 16.75
18.19
1 month 13.81
Extreme 13.81
18.19
Current year 8.7
Extreme 8.7
18.19
1 year 8.7
Extreme 8.7
18.19
3 years 8.7
Extreme 8.7
46.75
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
06-01Free

Chief Executive Officer

1,070,765 1.3758%
06-01Free

Executive/Senior Manager

92,281 0.1186%
05-09Tax

Director

-882 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
+1.43%+4.55%+45.64%-57.09% 1.36B
+2.20%+0.13%-33.18%-13.71% 154B
+1.17%+0.78%-6.82%-7.85% 103B
+1.63%+7.06%+62.45%+50.82% 55.68B
+0.01%+2.69%-4.76%+54.74% 54.76B
-0.25%-3.22%-15.71%-43.33% 40.1B
-0.64%+9.73% - - 31.57B
-1.43%-4.52%-10.77%-44.14% 28.64B
-0.56%+3.07%+48.52%-8.40% 23.41B
-0.76%-2.82%-14.91%-3.18% 20.6B
Average +0.28%+1.67%+7.83%-8.02% 51.38B
Weighted average by Cap. +0.88%+0.52%-5.51%-0.92%

Financials

2026 *2027 *
Net sales 1.68B 1.44B 1.33B 1.25B 2.34B 159B 2.37B 15.68B 6.11B 77.57B 6.29B 6.15B 269B 1.73B 1.49B 1.37B 1.29B 2.42B 164B 2.45B 16.2B 6.32B 80.16B 6.5B 6.36B 278B
Net income 42.73M 36.81M 33.86M 31.83M 59.79M 4.04B 60.48M 400M 156M 1.98B 160M 157M 6.85B 74.56M 64.24M 59.08M 55.54M 104M 7.05B 106M 698M 272M 3.45B 280M 274M 11.96B
Net Debt 1.34B 1.15B 1.06B 997M 1.87B 127B 1.89B 12.52B 4.88B 61.95B 5.02B 4.92B 215B 1.18B 1.01B 932M 876M 1.65B 111B 1.66B 11B 4.29B 54.43B 4.41B 4.32B 189B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
16/06/26 17.70 $ +1.37% 861,973
15/06/26 17.46 $ -1.74% 891,566
12/06/26 17.77 $ +1.48% 534,402
11/06/26 17.51 $ +2.46% 580,646
10/06/26 17.09 $ -4.53% 692,028
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
17.46USD
Average target price
17.43USD
Spread / Average Target
-0.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!